Clinical implication of adverse drug reaction surveillance in children

Eun Hee Chung

doi:10.4168/aard.2016.4.5.309

Journal List > Allergy Asthma Respir Dis > v.4(5) > 1059200

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Chung: Clinical implication of adverse drug reaction surveillance in children

Editorial

Allergy, Asthma & Respiratory Disease 2016; 4(5): 309-310.

Published online: 30 September 2016

DOI: https://doi.org/10.4168/aard.2016.4.5.309

Clinical implication of adverse drug reaction surveillance in children

Eun Hee Chung

Department of Pediatrics, Chungnam National University School of Medicine, Daejeon, Korea.

Correspondence to: Eun Hee Chung. Department of Pediatrics, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 35015, Korea. Tel: +82-42-280-7249, Fax: +82-42-255-3158, ehchung@cnu.ac.kr

Received 14 September 2016 Revised 27 September 2016 Accepted 27 September 2016

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).

References

1. Choi NK, Park BJ. Adverse drug reaction surveillance system in Korea. J Prev Med Public Health. 2007; 40:278–284.

2. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999; 88:965–968.

3. Choonara I, Conroy S. Unlicensed and off-label drug use in children: implications for safety. Drug Saf. 2002; 25:1–5.

4. Park GM, Park JH, Jung JW, Han HW, Kim JY, Lee E, et al. Pediatric adverse drug reactions collected by an electronic reporting system in a single tertiary university hospital. Allergy Asthma Respir Dis. 2016; 3:354–359.

5. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology, drug disposition, action, and therapy in infants and children. N Engl J Med. 2003; 349:1157–1167.

6. Stephenson T. How children's responses to drugs differ from adults. Br J Clin Pharmacol. 2005; 59:670–673.

7. Chung EH, Choi YJ, Suh DI, Woo SI, Cho HJ, Chung SY. Adverse drug reactions in Korean children: an analysis of KAERS database on 2012-2013 [abstract]. Program and Abstract, the 65th Annual Fall Meeting of the Korean Pediatric Society; 2015 Oct 22-23; Seoul, Korea. Seoul: The Korean Pediatric Society;2015. p. 65.

8. Chung EH, Suh DI, Woo SI, Cho HJ. Special interest group 2: Pediatric drug adverse reaction. Program and Abstract, the 13th Annual Spring Meeting of The Korean society for Pharmacoepidemiogy and Risk Management; 2014 May 30; Seoul, Korea. Seoul: The Korean society for Pharmacoepidemiogy and Risk Management;2014. p. 139.

9. Nor Aripin KN, Choonara I, Sammons HM. Systematic review of safety in paediatric drug trials published in 2007. Eur J Clin Pharmacol. 2012; 68:189–194.

10. Chung EH. Vaccine allergies. Clin Exp Vaccine Res. 2014; 3:50–57.

11. Hawcutt DB, Mainie P, Riordan A, Smyth RL, Pirmohamed M. Reported paediatric adverse drug reactions in the UK 2000-2009. Br J Clin Pharmacol. 2012; 73:437–446.

TOOLS

ORCID iDs: Eun Hee Chung
https://orcid.org/http://orcid.org/0000-0001-9380-0151
Similar articles